Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06437301 · ClinicalTrials.gov registry record · NA

End Tidal CO2 and Masks: Is There a Correlation?

A NA study, sponsored by CHRISTUS Health.

Completed
Registry status
NA
Development phase
31
Enrollment target

NCT06437301: Completed NA study, sponsored by CHRISTUS Health.

NCT06437301 is a NA study that has completed, run by CHRISTUS Health. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06437301, a NA study, has completed, sponsored by CHRISTUS Health.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target

Study Summary

In light of the ongoing COVID-19 pandemic, wearing a mask has become a universal standard as an attempt to reduce the spread of COVID-19. As of 2020, more than half of all U.S. states have implemented a state wide mandated mask policy. There are many schools of thought regarding the benefits and risks of donning a mask to prevent the spread of COVID-19. There is an unproven theory among some that wearing a mask interferes with our natural respiratory function, causing hypoxia, altered mental status and other various health issues. This dangerous perception has led some to believe wearing a mask is harmful, and encourages against wearing a mask in public. This theory, recently refuted by a study investigating oxygen levels while participants wore masks, performed in 2020 encouraged increased compliance with wearing masks. Another study, preformed by evaluated whether gas exchange abnormalities occurred with the use of surgical masks in subjects with and without lung function impairment. The conclusions of the study showed that regardless of lung function impairment, the presence of surgical masks did not impact gas exchange. Additionally, a more recent study concluded that the presence of a facemask did not have a significant change in physiologic parameters while during exercise. Although there is evidentiary support that facemasks do not negatively affect oxygen status and physiologic capacity, there is not strong evidence examining the relationship between ETCO2 and facemasks. The relationship between ETCO2 and facemasks is one of importance because mild decreases in oxygen have much less dangerous effects compared to the effects of rapid accumulations of carbon dioxide. Increases in end tidal carbon dioxide lead to confusion, acidosis and in severe cases, respiratory distress and failure. A study performed in 1989 showed that hypercapnia has greater increases in blood pressure, minute ventilation and sympathetic nerve activity than hypoxia. In this newly propose

Primary Outcome

The primary objective of this study is to evaluate if there are changes present with non-invasive end tidal carbon dioxide measurement while wearing a mask.

Interventions

  • OTHER Baseline measure of ETCO2 without mask
  • OTHER Baseline ETCO2 with mask
  • OTHER ETCO2 after 200 meter walk with mask
  • OTHER ETCO2 after 200 meter walk without mask

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2021-07-01
Est. Completion 2022-03-16
Phase NA
CHRISTUS Health

12 total trials

What the finished NCT06437301 record still lists

NCT06437301 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 4 interventions - of which Baseline measure of ETCO2 without mask is the first listed.

NCT06437301 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06437301 about?

NCT06437301 is a clinical study titled "End Tidal CO2 and Masks: Is There a Correlation?". In light of the ongoing COVID-19 pandemic, wearing a mask has become a universal standard as an attempt to reduce the spread of COVID-19. As of 2020, more than half of all U.S. states have implemented a state wide mandated mask policy. There are many schools of thought regarding the benefits and ris...

What is the current status of trial NCT06437301?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2021-07-01. Estimated completion is 2022-03-16.

What interventions are being tested in trial NCT06437301?

The interventions under investigation include: Baseline measure of ETCO2 without mask (OTHER), Baseline ETCO2 with mask (OTHER), ETCO2 after 200 meter walk with mask (OTHER), ETCO2 after 200 meter walk without mask (OTHER).

Who is sponsoring clinical trial NCT06437301?

This trial is sponsored by CHRISTUS Health, which has 12 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06437301's enrollment target sits among peer trials

31 1592nd of 2000 higher than 408 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06437301, the US trial registry maintained by the National Library of Medicine. NCT06437301 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.